biguanides has been researched along with fenofibrate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansquer, JC; Assadolahi, F; Cavallero, E; Corda, C; Dachet, C; Foucher, C; Jacotot, B; Juhan-Vague, I; Martin, C; Navarro, N | 1 |
| Veselovskaya, NN | 1 |
1 trial(s) available for biguanides and fenofibrate
| Article | Year |
|---|---|
Micronized fenofibrate normalizes the enhanced lipidemic response to a fat load in patients with type 2 diabetes and optimal glucose control.
Topics: Adult; Apolipoproteins B; Biguanides; Cholesterol, VLDL; Diabetes Mellitus, Type 2; Dietary Fats; Double-Blind Method; Fenofibrate; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Postprandial Period; Sulfonylurea Compounds; Treatment Outcome; Triglycerides | 2003 |
1 other study(ies) available for biguanides and fenofibrate
| Article | Year |
|---|---|
[CHANGES OF LIFETIME MORPHOLOGICAL PARAMETERS OF THE RETINA ON THE BACKGROUND OF CORRECTION OF LIPID METABOLISM IN PATIENTSWITH TYPE 2 DIABETES MELLITUS].
Topics: Aged; Biguanides; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fenofibrate; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Lipid Metabolism; Lipoproteins, HDL; Lipoproteins, LDL; Macula Lutea; Male; Middle Aged; Tomography, Optical; Visual Acuity | 2017 |